Forefront Wealth Management’s Guardant Health GH Stock Holding History

Forefront Wealth Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$204K	Buy	+2,000	New	+$179K	0.15%	68

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Forefront Wealth Management's GH Position: Q4 2025 in Review

Forefront Wealth Management opened a new position in Guardant Health (GH) in Q4 2025: 2,000 shares worth $204K. The stake represents 0.15% of the portfolio and ranks #68 among its holdings.

497 funds tracked by Wall St. Rank hold GH as of Q4 2025.

Forefront Wealth Management held 2,000 shares of Guardant Health worth $204K as of Q4 2025.
Guardant Health was a new Forefront Wealth Management position in Q4 2025.
Guardant Health made up 0.15% of Forefront Wealth Management's portfolio in Q4 2025, its #68 holding.
497 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on Forefront Wealth Management's 13F filing for Q4 2025, filed 23 Jan 2026.